Method for improving embryonic stem cell to differentiate to cardiac muscle cell

A technology of embryonic stem cells and cardiomyocytes, applied in the field of promoting the differentiation of embryonic stem cells into cardiomyocytes, can solve problems such as shortage, limited service life, and limitation

Inactive Publication Date: 2007-11-21
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Heart transplantation or implantation of a left ventricular mechanical support system can save the life of patients with e

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving embryonic stem cell to differentiate to cardiac muscle cell
  • Method for improving embryonic stem cell to differentiate to cardiac muscle cell
  • Method for improving embryonic stem cell to differentiate to cardiac muscle cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1 Culture and in vitro induced differentiation of embryonic stem cells

[0058] The mouse R1 embryonic stem (ES) line (Roder JC, Canada, purchased from ATCC, USA) was cultured on trophoblast cells, and the trophoblast cells were selected from primary mouse embryonic fibroblasts treated with mitomycin C (purchased from SIGMA) (derived from outbred Kunming white mouse, 13-15 days old embryo), cultured in DMEM, added 15% fetal bovine serum (purchased from Hyclone Company, ES cell qualified), L-glutamic acid, P-S (penicillin + streptomycin element), non-essential amino acids, (purchased from GIBCO, diluted 100X), β-mercaptoethanol (0.0007%), passaged for an average of 36 hours. 0.2% Trypsin-EDTA (purchased from GIBCO) was used for subculture.

[0059] The hanging drop culture method was used to induce differentiation in vitro, and the appropriate cell density (1.5-3.0×10 6 Cells / petri dish (diameter 60mm)) of mouse R1 embryonic stem cells (digested into a singl...

Embodiment 2

[0060] Example 2 Plasmid Construction and Transfection of ES Cells

[0061] Firstly, the vector plasmid pEGFP-N1 (BD, purchased from Clontech) was used to digest with the endonuclease AatII and then the large fragments were self-ligated to inactivate the original CMVIE promoter, and then the inactivated gene was cut with the endonuclease PstI. Carrier, and then the cloned myocardial-specific sodium-calcium exchange protein type I gene promoter (cloned from genomic DNA by conventional methods, or can be purchased from NIH / NIA Institute) was cut out with endonuclease PstI, and T4 Ligase ligation, the resulting clones were identified by digestion with PstI, SalI, and Asel, respectively, and positive clones that were correctly inserted were picked out, and a large number of amplified plasmids were used for transfection. The linearized plasmid was digested with Asel to obtain 15 μg of the linearized plasmid, and transfected into ES cells using an electroporator (BioRad, GenePulser)...

Embodiment 3

[0065] Example 3 Hypoxic culture of ES cells to induce differentiation

[0066] Normal cultured ES cells (ES cells transfected with a sodium-calcium exchange protein promoter to drive the green fluorescent protein (NCX1) gene) were made into hanging drops and divided into a hypoxic treatment group and a normal control group.

[0067] The cells in the hypoxic treatment group were cultured in a hypoxic incubator (Thermo Forma) with a culture condition of 3% O 2 , 5% carbon dioxide, and continued to culture for 48 hours (2 days), while the cells of the normal control group were in 21% O 2 , 5% CO 2 After the hanging drop culture, the two groups of cells were cultured under normal oxygen concentration conditions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A method for improving embryo dry cell differentiation to heart muscle cell is carried out by placing embryo dry cell culture under low-oxygen environment culturing for some time and oriented inducing. It adopts low-oxygen treatment and has higher acquired rate. It's simple, cheap and controllable.

Description

technical field [0001] The invention relates to the fields of biotechnology and medicine, more specifically, the invention relates to a method for promoting the differentiation of embryonic stem cells into cardiomyocytes. Background technique [0002] Embryonic stem cells (ES) are a kind of totipotent / pluripotent stem cells, derived from the inner cell mass of blastocyst-stage embryos, which can not only develop and differentiate in vivo to form various tissues and organs of newborn individuals, but also can be cultured in vitro Induce differentiation to form various specialized cell types, such as ventricular myocytes, smooth muscle cells, endothelial cells, erythrocytes, islet cells, etc. The success of in vitro establishment of human embryonic stem cells and the maturity of induced differentiation technology make embryonic stem cells an important cell source for clinical organ transplantation therapy and cell transplantation therapy. [0003] Myocardial infarction (MI) c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/06C12N5/08C12N5/077
Inventor 杨黄恬王嵘
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap